🇺🇸 FDA
Pipeline program

68Ga-Pentixafor

PUMCH-68Ga-CXCR4-Cushing

Phase 2 small_molecule active

Quick answer

68Ga-Pentixafor for Cushing s Syndrome is a Phase 2 program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Peking University Third Hospital
Indication
Cushing s Syndrome
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials